The PAN Foundation opens new amyloidosis patient assistance fund

For immediate release

PAN Foundation contact:

Maggie Naples, Director of Marketing and Communications

Washington, D.C. (May 14, 2019) – The PAN Foundation today opened a new patient assistance program for people living with amyloidosis. Amyloidosis is a group of diseases characterized by a protein build-up in specific organs or throughout the body. The American Society of Clinical Oncology estimates that there are approximately 4,000 new cases of amyloidosis each year. Qualifying patients are eligible to receive grants from PAN to pay for the deductibles, copays and coinsurance costs associated with their amyloidosis treatment.

“Amyloidosis is a rare and sometimes life-threatening illness that often requires extensive and ongoing treatment,” says PAN President and CEO Daniel Klein. “Thanks to our donors, we’re grateful to alleviate some of the financial burden for patients diagnosed with amyloidosis, so they can focus on managing their condition and staying the course of treatment.”

Patients who qualify for the PAN Foundation’s Amyloidosis Assistance Program are eligible to receive $7,800 per year in financial assistance. Eligible patients must be getting treatment for amyloidosis; must reside and receive treatment in the United States; must have Medicare health insurance; and the medication for which they seek assistance must be covered by their insurance and must be listed on PAN’s list of covered medications. In addition, the patient’s income must fall at or below 500 percent of the Federal Poverty Level.

Patients, or advocates and caregivers applying on their behalf, can apply for assistance using the PAN Foundation’s online patient portal (, or by calling 1-866-316-7263, 9 a.m. to 7 p.m. Eastern Time, Monday through Friday. To learn more about PAN’s nearly 70 disease-specific programs, visit

About the PAN Foundation:

The PAN Foundation is an independent, nationwide 501(c)3 organization dedicated to providing help and hope to underinsured patients who are unable to afford the out-of-pocket expenses for their prescribed medications. Since 2004, PAN has provided over $3 billion in financial assistance to nearly 1 million patients who would otherwise be unable to afford their medications. To learn more, visit